Nguyen Binh 4
4 · ENDOCYTE INC · Filed May 23, 2013
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Nguyen Binh
VP of Clinical Affairs
Transactions
- Exercise/Conversion
Common Stock
2013-05-22$3.55/sh+2,700$9,585→ 2,700 total - Exercise/Conversion
Stock Option (right to buy)
2013-05-22−2,700→ 60,000 totalExercise: $3.55Exp: 2022-02-28→ Common Stock (2,700 underlying)
Footnotes (1)
- [F1]This option is fully vested and immediately exercisable.